A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia

NCT ID: NCT03997656

Last Updated: 2019-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2021-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The modern world revolves around technology; unsurprisingly companies are leveraging the expertise of the digital tech industry to aid in the prevention of chronic diseases. Among one of the most common chronic diseases in Malaysia is diabetes. Prevalence of diabetes in Malaysia has increased by more than two folds over the past two decades. Despite a growing number of tech products developments on diabetes prevention, a recent meta-analysis has found almost no evidence on digital therapy outside the developed world. Therefore, this study is needed to demonstrate the potential of digital therapy in preventing diabetes in Malaysia. The study design is a randomized controlled trial study conducted in Kuala Terengganu, Malaysia. The study will be conducted in two phases. The first phase will involve preparation of intervention modules and development of intervention mobile app. The second phase will involve validation and utilization of the digital therapy. We hope that this digital therapy program can make a significant difference in health outcomes, especially for diabetes. By giving precise regimes and daily monitoring, digital therapeutics can offer mountains of data that can potentially provide doctors unprecedented insights into patient behavior and create feedback or optimization loops for individual patients. Enabling patients to take greater control over managing their chronic illnesses and preventing disease progression could save billions of ringgits throughout the entire Malaysia healthcare system. By that, we hope this approach can be considered as a scalable solution to address national diabetes prevention efforts to target of improvement on diabetes prevalence to not more than 15% by 2025 and serve as a model for applying such services to other chronic diseases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Digital therapy is a new field that has emerged as the evidence-based treatments from the field of behavioural medicine that are delivered online. It is considered as a scalable method to reach a large number of at-risk population, convenient and accessible. Furthermore, it frees participants from the requirement of travelling to a specific location and more flexible with the time to participate. The aim of this study therefore to determine the feasibility and efficacy of a lifestyle intervention for type 2 diabetes prevention in adults at risk of developing diabetes, an assessor-blinded, parallel-group, randomised controlled trial using the MyDiPP (Malaysia Diabetes Prevention Programme) app. Eligible participants were stratified (age, BMI) and then randomised in a 1:1 ratio to either the 12-month MyDiPP intervention or receive standard health education from primary care providers in the clinic. The study will be conducted in two phases. The first phase will involve preparation of intervention modules, development of intervention mobile app, training and recruitment of participants. The second phase of the study will involve implementation of the intervention, data collection, follow up and data analyses. The study will be conducted in individuals aged 18- to 65-years old, living, working or studying in Kuala Terengganu who is at risk developing diabetes but currently does not have diabetes recruited through online advertisement. The target population is adult residents that lived, worked or studied in Kuala Terengganu who is identified as being at high risk of type 2 diabetes. One hundred participants will be recruited for this study. They will be identified by a two-stage screening process. In the first stage, patients at high risk of type 2 diabetes will be identified via the CDC Diabetes Risk Test that will be distributed via Google Form. The researcher will invite those who scored ≥5 for second stage screening test via the HbA1c test. In the second stage, patients attending a screening for eligibility who have a current HbA1c in the range 38-44 mmol/mol or 5.6-6.2% will be invited to volunteer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pre Diabetes Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Control group
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators
Single-blinded approach

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MyDipp

The participants will go through 16-weekly core lessons that need to be completed within the first 24 weeks after randomisation focusing on changing dietary habits, increase physical activity and relapse prevention and 6-monthly post-core lessons focusing on maintenance of lifestyle habits and weight loss achieved during the core program. Each lesson will take 30 to 60 minutes to complete. The lesson will be considered complete if the participants clicked through all of the pages and answered multiple choice questions to indicate engagement and understanding.

Group Type EXPERIMENTAL

MyDiPP (Malaysia Diabetes Prevention Program)

Intervention Type BEHAVIORAL

The participants will go through 16-weekly core lessons that need to be completed within the first 24 weeks after randomisation focusing on changing dietary habits, increase physical activity and relapse prevention and 6-monthly post-core lessons focusing on maintenance of lifestyle habits and weight loss achieved during the core program.

Control

Participants in the control group (usual care) will receive standard health education from primary care providers in the clinic. In addition, they also will be provided with pamphlets and booklets about various health topics. They will be given a diary to record their weights, diet, physical activities and blood test result.

Group Type OTHER

usual care

Intervention Type OTHER

standard health education from primary care providers in the clinic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MyDiPP (Malaysia Diabetes Prevention Program)

The participants will go through 16-weekly core lessons that need to be completed within the first 24 weeks after randomisation focusing on changing dietary habits, increase physical activity and relapse prevention and 6-monthly post-core lessons focusing on maintenance of lifestyle habits and weight loss achieved during the core program.

Intervention Type BEHAVIORAL

usual care

standard health education from primary care providers in the clinic

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18-65 years old
* body mass index (BMI) of ≥23 kg/m2,
* high risk for diabetes (diabetes risk test score ≥5 \[22\] or HbA1c of 38-44 mmol/mol or 5.6-6.2%
* ownership of a smartphone (Android only) for communication defined as logging on at least once/day to the internet
* being fluent in Malay or English languages and
* had no contradictions to participate in weight management program or physical activity.

Exclusion Criteria

* clinical history of diabetes or newly diagnosed diabetes at the time of screening where HbA1c level ≥45 mmol/mol or ≥6.3%
* taking oral anti-diabetic agents
* participating in a concurrent weight management program or interventional research protocol
* on a prescribed medical diet, anti-obesity or diabetes therapy within the preceding 4 months
* had clinical history of cardiovascular diseases occurred within the past 6 months
* any form of cancers that require treatment
* dementia or probable Alzheimer's disease
* advanced arthritis
* pregnant or within 6 weeks of having given birth or planning to become pregnant in the next 12 months
* existing liver and renal disease and having hyperthyroidism
* any mental health condition including eating disorder or alcohol/substance use
* other causes which could interfere with participation (for examples physically disabled)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universiti Sultan Zainal Abidin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sharifah Wajihah Wafa T Syed Saadun Tarek Wafa, PhD

Role: PRINCIPAL_INVESTIGATOR

Universiti Sultan Zainal Abidin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Sultan Zainal Abidin

Kuala Terengganu, Terengganu, Malaysia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sharifah Wajihah Wafa Syed Saadun Tarek Wafa, PhD

Role: CONTACT

+60126911510

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sharifah Wajihah Wafa Syed Saadun Tarek Wafa, PhD

Role: primary

126911510

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018/77

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Feel4Diabetes-study
NCT02393872 UNKNOWN NA
Program ACTIVE: Phase 2
NCT04369001 WITHDRAWN NA
Live Your Life Without Diabetes
NCT03663803 COMPLETED NA